04/08/2020 | BioRegio STERN Management GmbH | Press

Start-up from Tübingen joins fight against coronavirus

PRiME Vector Technologies receives seven-figure sum to develop Covid-19 vaccine

(Stuttgart/Tübingen) - Newly founded PRiME Vector Technologies GmbH produces highly effective vaccines using an innovative platform technology that enables vaccine vectors to be tailored to all kinds of different requirements. Germany's Federal Ministry for Economic Affairs and Energy (BMWi) is giving the company 1.3 million euros with immediate effect to develop a Covid-19 vaccine. The Carl Zeiss Foundation is also contributing 150,000 euros to the project.

BioRegio STERN Management GmbH